The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma

Andrea Di Cristofori(University of Milan), Valentina Vaira(University of Milan)
Oncotarget
May 22, 2015
10.18632/oncotarget.4239
Cited by 69

Related Papers

Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women
|Nature Medicine|2023|130
Rare ATG7 genetic variants predispose patients to severe fatty liver disease
|Journal of Hepatology|2022|93
A GBM-like V-ATPase signature directs cell-cell tumor signaling and reprogramming via large oncosomes
|EBioMedicine|2019|44
Perilesional resection technique of glioblastoma: intraoperative ultrasound and histological findings of the resection borders in a single center experience
|Journal of Neuro-Oncology|2023|11